Answers are grounded in this paper and cite their sources.
The discovery that would have the greatest impact on our field would be the development of accurate imaging. Patrick C. Walsh, Whitmore Lecture, 2008 AUA Meeting1 True to that prediction, the advent of multiparametric MRI to guide prostate biopsy set the stage for a “sea change” in prostate cancer management. Not since the advent of PSA in the 1990s has a change been so impactful. MRI visualization of cancer leads to targeted biopsy, which leads to accurate characterization of prostate pathology, which leads to treatments more rational than those in the past. As clearly shown in the report by Goldman et al,2 adoption of the new technology has been dramatic. As of year-end 2021, more than half of repeat biopsies in the United States (and nearly one-third of first biopsies) were being performed with an MRI beforehand (Figures 1 and 2). The first published MRI of the prostate is attributed to Hricak in 1983.3 The first known MRI-guided biopsy was performed by D’amico et al in 2000.4 However, it was not until MRI/US fusion devices became available for prostate biopsy in 2008 (Artemis) and 2009 (UroNav) that use of prebiopsy MRI began to increase. The Walsh prediction thus became reality as urologists embraced MRI to guide biopsy (or to decide whether biopsy were needed). The Goldman paper is an excellent overview, an exhaustive dive into huge databases of insurance patients (MarketScan) and Medicare patients. An interesting spinoff is the finding that men undergoing repeat biopsy with the aid of MRI guidance were some 50% more likely to undergo radical prostatectomy than men having biopsy without MRI guidance (15.9% vs 10.4%). Increased sensitivity of MRI guidance for biopsy detection of high-grade tumors is a possible explanation. Now that the adoption of prebiopsy MRI has been documented in a general way, the next analysis should look at specifics. How were the biopsies performed? How expert was the MRI performance and interpretation? The latter question is critical because most urologists are not trained in the vagaries of Prostate Imaging Reporting and Data System scoring, and there is still no radiologic credentialing to establish expertise in prostate MRI. For future writing of this open book, we urologists should remain the main authors!
No takes yet. Share an insight, caveat, or question.
Leonard S. Marks (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: